Black Rock Inc. Heron Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,325,385 shares of HRTX stock, worth $13.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,325,385
Previous 7,286,028
14.27%
Holding current value
$13.3 Million
Previous $20.2 Million
44.38%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRTX
# of Institutions
179Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$42.7 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$14.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$14 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$11.2 Million28.8% of portfolio
-
Tejara Capital LTD London, X05.31MShares$8.49 Million5.03% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $190M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...